Comment
Author: Admin | 2025-04-28
ClonazePAM Images clonazepam 1 mg clonazepam 0.5 mg clonazepam 0.5 mg clonazepam 0.5 mg clonazepam 2 mg clonazepam 0.5 mg Drug InteractionsAlcohol (Ethyl): CNS Depressants may enhance the CNS depressant effect of Alcohol (Ethyl). Monitor therapyAlizapride: May enhance the CNS depressant effect of CNS Depressants. Monitor therapyAprepitant: May increase the serum concentration of CYP3A4 Substrates (High risk with Inhibitors). Monitor therapyAzelastine (Nasal): CNS Depressants may enhance the CNS depressant effect of Azelastine (Nasal). Avoid combinationBlonanserin: CNS Depressants may enhance the CNS depressant effect of Blonanserin. Consider therapy modificationBosentan: May decrease the serum concentration of CYP3A4 Substrates (High risk with Inducers). Monitor therapyBrexanolone: CNS Depressants may enhance the CNS depressant effect of Brexanolone. Monitor therapyBrimonidine (Topical): May enhance the CNS depressant effect of CNS Depressants. Monitor therapyBromopride: May enhance the CNS depressant effect of CNS Depressants. Monitor therapyBromperidol: May enhance the CNS depressant effect of CNS Depressants. Avoid combinationBuprenorphine: CNS Depressants may enhance the CNS depressant effect of Buprenorphine. Management: Consider reduced doses of other CNS depressants, and avoiding such drugs in patients at high risk of buprenorphine overuse/self-injection. Initiate buprenorphine at lower doses in patients already receiving CNS depressants. Consider therapy modificationCannabidiol: May enhance the CNS depressant effect of CNS Depressants. Monitor therapyCannabis: May enhance the CNS depressant effect of CNS Depressants. Monitor therapyChlormethiazole: May enhance the CNS depressant effect of CNS Depressants. Management: Monitor closely for evidence of excessive CNS depression. The chlormethiazole labeling states that an appropriately reduced dose should be used if such a combination must be used. Consider therapy modificationChlorphenesin Carbamate: May enhance the adverse/toxic effect of CNS Depressants. Monitor therapyClofazimine: May increase the serum concentration of CYP3A4 Substrates (High risk with Inhibitors). Monitor therapyCloZAPine: Benzodiazepines may enhance the adverse/toxic effect of CloZAPine. Management: Consider decreasing the dose of (or possibly discontinuing) benzodiazepines prior to initiating
Add Comment